GLUE Monte Rosa Therapeutics Inc stock rises after Q4 2025 earnings even as quarterly losses exceed analyst expectations Jefferson Capital JCAP Volume Analysis Q4 2025 EPS Exceeds Expectations Why Range RANGR Stock Is Volatile 064 20260416